%PDF-1.4
%
1 0 obj
<>
endobj
4 0 obj
<>stream
2018-02-08T16:06:05+05:30
Arbortext Advanced Print Publisher 9.1.510/W Unicode
2018-09-17T04:11:17-07:00
2018-09-17T04:11:17-07:00
Acrobat Distiller 10.0.0 (Windows)
application/pdf
A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL
uuid:663fbef1-1dd2-11b2-0a00-060a27bda400
uuid:663fbef6-1dd2-11b2-0a00-5c0000000000
endstream
endobj
3 0 obj
<>
endobj
2 0 obj
<>
endobj
5 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/Rotate 0/Thumb 14 0 R/Type/Page>>
endobj
6 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 25 0 R/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 29 0 R/Type/Page>>
endobj
8 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 32 0 R/Type/Page>>
endobj
9 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 35 0 R/Type/Page>>
endobj
10 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 38 0 R/Type/Page>>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 41 0 R/Type/Page>>
endobj
12 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 49 0 R/Type/Page>>
endobj
199 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
251 0 obj
[255 0 R 256 0 R 257 0 R 258 0 R 259 0 R 260 0 R 261 0 R 262 0 R 263 0 R 264 0 R]
endobj
252 0 obj
<>stream
q
184.8032227 0 0 46.2008057 72 663.7991943 cm
/Im0 Do
Q
BT
/T1_0 1 Tf
10 0 0 10 262 659.99988 Tm
(online December 18, 2017)Tj
15.62098 1 Td
( originally published)Tj
/T1_1 1 Tf
-15.62098 0 Td
(doi:10.1182/blood-2017-06-792333)Tj
0 1.00001 TD
(2018\240131: 955-962)Tj
/T1_0 1 Tf
0 1 TD
(\240)Tj
T*
(\240)Tj
ET
BT
/T1_1 1 Tf
10 0 0 10 72 571.99982 Tm
(Ritgen, Sebastian B\366ttcher, Anton W. Langerak, Michael Kneba and Mich\
ael Hallek)Tj
T*
(Bahlo, Kirsten Fischer, Barbara Eichhorst, Valentin Goede, Jacques J. M.\
van Dongen, Matthias )Tj
0 1.00001 TD
(Natalie Dimier, Paul Delmar, Carol Ward, Rodica Morariu-Zamfir, G\374nte\
r Fingerle-Rowson, Jasmin)Tj
0 1 TD
(\240)Tj
/T1_2 1 Tf
13 0 0 13 72 611.99994 Tm
(using MRD as a surrogate end point in CLL)Tj
T*
(A model for predicting effect of treatment on progression-free survival)Tj
/T1_1 1 Tf
T*
(\240)Tj
ET
72 538 m
521 538 l
0 0 m
S
BT
0 0 1 rg
/T1_2 1 Tf
10 0 0 10 72 513.99994 Tm
(http://www.bloodjournal.org/content/131/9/955.full.html)Tj
0 g
/T1_1 1 Tf
T*
(Updated information and services can be found at:)Tj
ET
BT
/T1_1 1 Tf
10 0 0 10 172.58997 479.99994 Tm
( \(2879 articles\))Tj
0 0 1 rg
-9.05899 0 Td
(Lymphoid Neoplasia)Tj
0 g
/T1_0 1 Tf
-1.00001 0 Td
(\240\240\240 )Tj
/T1_1 1 Tf
15.05898 1 Td
( \(4829 articles\))Tj
0 0 1 rg
-14.05897 0 Td
(Clinical Trials and Observations)Tj
0 g
/T1_0 1 Tf
-1.00001 0 Td
(\240\240\240 )Tj
/T1_1 1 Tf
0 1.00001 TD
(Articles on similar topics can be found in the following Blood collectio\
ns)Tj
ET
72 463 m
521 463 l
0 0 m
S
BT
0 0 1 rg
/T1_2 1 Tf
10 0 0 10 72 438.99994 Tm
(http://www.bloodjournal.org/site/misc/rights.xhtml#repub_requests)Tj
0 g
/T1_1 1 Tf
0 1 TD
(Information about reproducing this article in parts or in its entirety m\
ay be found online at:)Tj
ET
BT
0 0 1 rg
/T1_2 1 Tf
10 0 0 10 72 400.99997 Tm
(http://www.bloodjournal.org/site/misc/rights.xhtml#reprints)Tj
0 g
/T1_1 1 Tf
T*
(Information about ordering reprints may be found online at:)Tj
ET
BT
0 0 1 rg
/T1_2 1 Tf
10 0 0 10 72 362.99997 Tm
(http://www.bloodjournal.org/site/subscriptions/index.xhtml)Tj
0 g
/T1_1 1 Tf
T*
(Information about subscriptions and ASH membership may be found online a\
t:)Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
10 0 0 10 72 41.99991 Tm
(\240 )Tj
T*
(Copyright 2011 by The American Society of Hematology; all rights reserve\
d.)Tj
0 g
0 1.00001 TD
(of Hematology, 2021 L St, NW, Suite 900, Washington DC 20036.)Tj
0 1 TD
(Blood \(print ISSN 0006-4971, online ISSN 1528-0020\), is published week\
ly by the American Society)Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
9 0 0 9 360.7863 766 Tm
(For personal use only.)Tj
0 g
-11.00699 0 Td
(on September 17, 2018. )Tj
-4.05799 0 Td
(by guest )Tj
/T1_0 1 Tf
8 0 0 8 223.20149 766 Tm
( )Tj
0 0 1 rg
/T1_1 1 Tf
9 0 0 9 136.67564 766 Tm
(www.bloodjournal.org)Tj
0 g
-2.61097 0 Td
(From )Tj
ET
endstream
endobj
254 0 obj
<>/Filter/FlateDecode/Height 132/Length 26933/Name/X/Subtype/Image/Type/XObject/Width 528>>stream
H TW &Ȣ`A"
B$.cmZw-VBE[uZV
jq!Iqc7}D ! a $d|S&' pB+4d2Fgc9`
hzlڹKX]]īͷ`*T>P+/%[2qgGCCfHY$rlIq'XL*T>\
^1)"z70l./dr`&<{+N`DGx%fz q̇N~Wz
.SBy
tƚ?ژSB
Շ"B&#)\iGzqUKIO VvqKs
6;o;|?R
̼445폟ҳ9Y V[}lPB5%e%UDFΘ#lmT:^$ftuvJ!Dr%+pT]qvSzEgSų}7B7|0I$2|PBKĝ/&Ź 擇o1AL*u,olr^T<ŘDFGST:Aܺ}⦭ʳk?`22{fyY+Lh]۱?m6rFhjkTC_mԚ(輠vLjrY)u E
+ר;/T"(x
hwna8_f0% q'8:Ymn0Y~
:VӪ HݸN.pCky=64p`7qy>֛